Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: mvaar....

RE: mvaar....

posted on Jun 27, 2005 07:53PM
-Townsend will not get 40% of licensing fees, unless litigation is required.. hopefully that will only be rarely

-TPL will probably get close to 50%..

And now B&O wants their cut too - perhaps another 40%. Normally contingencies are tied to the patent(s) not to the litigation.

-Forgive me for my technical analysis here but.. that is a load of crap

Share
New Message
Please login to post a reply